Minimal change nephrotic syndrome with stiff-person syndrome: Is there a link?

American Journal of Kidney Diseases

Volumn 46, Issue 1, 2005, Pages

  Ergün, Ihsan ^a   Akbostanci, M Cenk ^a   Canbakan, Başol ^a   Koçer, Bilge ^a   Ensari, Arzu ^a   Nergizoǧlu, Gökhan ^a   Keven, Kenan ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Minimal change disease; Nephrotic syndrome; Stiff man syndrome; Stiff person syndrome

Indexed keywords

CYCLOPHOSPHAMIDE; DIAZEPAM; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; LABORATORY TEST; MALE; NEPHROTIC SYNDROME; PATHOGENESIS; STIFF MAN SYNDROME; T LYMPHOCYTE; TREATMENT OUTCOME;

ADULT; CYCLOPHOSPHAMIDE; DIAZEPAM; DRUG THERAPY, COMBINATION; ELECTROMYOGRAPHY; HUMANS; IMMUNITY, CELLULAR; IMMUNOSUPPRESSIVE AGENTS; MALE; METHYLPREDNISOLONE; MUSCLE RELAXANTS, CENTRAL; NEPHROSIS, LIPOID; NEPHROTIC SYNDROME; PREDNISOLONE; REMISSION INDUCTION; STIFF-PERSON SYNDROME; T-LYMPHOCYTE SUBSETS;

EID: 20544452480     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2005.03.009     Document Type: Article

References (15)

1. O.M. Vanconcelos, M.C. Dalakas Stiff-person syndrome Curr Treat Options Neurol 5 2003 79 90
2. M.K. Flocter Inhibitory pathways defined by electrophysiology, in Levy LM (moderator): The stiff-person syndrome: An autoimmune disorder affecting neurotransmission of γ-aminobutyric acid Ann Intern Med 131 1999 522 530
3. M. Hummel, I. Durinovic-Bello, E. Bonifacio Humoral and cellular immune parameters before and during immunosuppressive therapy of a patient with stiff-man syndrome and insulin dependent diabetes mellitus J Neurol Neurosurg Psychiatry 65 1998 204 208
4. C.G. Goetz Textbook of Clinical Neurology (ed 2) 2003 Elsevier Philadelphia, PA 72
5. T. Chang, B. Lang GAD antibodies in stiff-person syndrome Neurology 63 2004 1999 2000
6. G. Rakocevic, R. Raju, M.C. Dalakas Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome Correlation with clinical severity Arch Neurol 61 2004 902 904
7. M. Costa, A. Saiz, R. Casamitjana T-Cell reactivity to glutamic acid decarboxylase in stiff-man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity Clin Exp Immunol 129 2002 471 478
8. P.W. Mathieson Immune dysregulation in minimal change nephropathy Nephrol Dial Transplant 18 suppl 6 2003 S26 S29
9. M.G. Surany, A. Guasch, B.M. Hall, B.D. Myers Elevated levels of tumor necrosis factor-α in the nephrotic syndrome in humans Am J Kidney Dis 21 1993 251 259
10. R. Cunard, C.J. Kelly T Cells and minimal change disease J Am Soc Nephrol 13 2002 1409 1411
11. M.C. Dalakas, M. Fujii, M. Li, B. Lutfi, J. Kyhos, B. McElroy High dose intravenous immune globulin for stiff-person syndrome N Engl J Med 345 2001 1870 1876
12. C. Wessig, R. Klein, M.F. Schneider, K.V. Toyka, M. Naumann, C. Sommer Neuropathology and binding studies in anti-amphiphysin-associated stiff-person syndrome Neurology 61 2003 195 198
13. S. Kagiyama, H. Tsuruta, M. Tominaga Minimal change nephrotic syndrome and acute renal failure in a patient with aged onset insulin-dependent diabetes mellitus and autoimmune thyroiditis Am J Nephrol 19 1999 369 372
14. M. Ilyas, A. Tolaymat Minimal change nephrotic syndrome with Guillain-Barré syndrome Pediatr Nephrol 19 2004 105 106
15. S. Holt, E. Kingdon, D. Morganstein, P. Sweny Simultaneous relapse of Graves' disease and minimal change glomerular disease Nephrol Dial Transplant 17 2002 666 668